The safety, effectiveness and cost‐effectiveness of cytisine in achieving six‐month continuous smoking abstinence in tuberculosis patients—protocol for a double‐blind, placebo‐controlled randomized trial

BACKGROUND AND AIMS: Tuberculosis (TB) patients who quit smoking have much better disease outcomes than those who continue to smoke. In general populations, behavioural support combined with pharmacotherapy is the most effective strategy in helping people to quit. However, there is no evidence for t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Addiction
Autors principals: Dogar, Omara, Barua, Deepa, Boeckmann, Melanie, Elsey, Helen, Fatima, Razia, Gabe, Rhian, Huque, Rumana, Keding, Ada, Khan, Amina, Kotz, Daniel, Kralikova, Eva, Newell, James N., Nohavova, Iveta, Parrott, Steve, Readshaw, Anne, Renwick, Lottie, Sheikh, Aziz, Siddiqi, Kamran
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Trial Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6099220/
https://ncbi.nlm.nih.gov/pubmed/29676824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/add.14242
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars